InspireMD has received CE Mark approval for its self-expanding Nitinol carotid embolic protection stent (EPS), which is based on the MicroNet mesh protection platform technology used to treat heart attack patients with InspireMD’s coronary EPS stents, MGuard and MGuard Prime.
The InspireMD Carotid EPS is wrapped with a MicroNet mesh to prevent embolic events during and post CAS procedure. The MicroNet is designed to hold plaque and thrombus in place against the wall of the blocked artery. The new InspireMD carotid EPS stent will be available in a matrix of sizes ranging from small diameters of 5x20mm to large diameters up to 10x60mm for large carotid arteries.
MGuard EPS is CE Mark approved. InspireMD said its MGuard EPS Coronary EPS also have CE Mark approval, but none are approved for sale in the U.S. by the FDA.